Furosemide
- Product NDC
- 64980-562
- 11-digit product format
- 649800562
- Labeler code
- 64980
- Product ID
- 64980-562_458b3c62-666c-43f2-8feb-ee8e6cbe8931
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Furosemide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Pharma Holdings, Inc.
- Application
- ANDA216629
- Marketing category
- ANDA
- Marketing start
- 2022-11-05
- Substance
- FUROSEMIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216629-001 | FUROSEMIDE | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | |
| A216629-002 | FUROSEMIDE | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | |
| A216629-003 | FUROSEMIDE | FUROSEMIDE | 80MG | TABLET / ORAL | AB | RS | 2022-10-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A216629-001 | AB |
| A216629-002 | AB |
| A216629-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A216629-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A216629-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | RS | 2022-10-17 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216629-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216629-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | RS | 2022-10-17 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A216629-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A216629-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2022-10-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216629-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216629-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2022-10-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216629-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216629-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2022-10-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216629-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216629-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2022-10-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216629-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216629-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2022-10-17 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216629-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216629-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2022-10-17 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216629-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216629-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2022-10-17 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A216629-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A216629-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2022-10-17 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216629-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216629-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2022-10-17 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216629-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216629-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2022-10-17 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216629-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2022-10-17 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216629-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2022-10-17 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A216629-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2022-10-17 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A216629-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A216629-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A216629-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216629-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216629-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216629-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A216629-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A216629-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A216629-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216629-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216629-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216629-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216629-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216629-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216629-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216629-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216629-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216629-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216629-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216629-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216629-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216629-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216629-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216629-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216629-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216629-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216629-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A216629-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A216629-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A216629-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216629-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216629-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216629-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216629-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216629-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216629-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216629-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216629-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216629-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A216629-001 | AB | 1 | 8072bd15b7f6… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Furosemide
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| FUROSEMIDE | 20 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7LXU5N7ZO5 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6101b9b4-f3ef-438e-a857-b4ea55ffc679 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d80d3aff-3a63-4d7b-a2be-fd9388b04330 | Product name | 9 | 20250806 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
| 9061e89f-9c86-4196-b34b-886fc1673cc4 | Product name | 1 | 20140821 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64980-562-01 | Furosemide | 100 in 1 BOTTLE | TABLET | 100 | 4 | |
| 64980-562-10 | Furosemide | 1000 in 1 BOTTLE | TABLET | 1000 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 64980-562-01 | EA - Each | 64980-562 | 1350f207-5fa3-4d28-b38e-7605eb7624c7 | 1 | 2022-11-07 |
| 64980-562-10 | EA - Each | 64980-562 | 8e6af091-583a-41ea-b0d4-5a38f5c90f1f | 1 | 2022-11-07 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | St. Mary's Medical Park Pharmacy | febeaf8c-0f4b-cc40-e053-6394a90a873e | 2026-06-30 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | Redpharm Drug | 37457273-38a1-f938-e063-6294a90a50ab | 2026-04-15 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | dba00759-87b4-4ecf-998e-ba03ed3d2f1a | 2026-04-15 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | Preferred Pharmaceuticals Inc. | adda78ee-0cf5-4613-a748-5d6571afe354 | 2026-01-19 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 8f56d6f6-a5ea-4171-9e24-d2fdb11a65f8 | 2026-01-13 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | Northwind Health Company, LLC | 13ba97a7-598a-76a4-e063-6294a90a45c5 | 2026-01-02 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | Redpharm Drug | 3745be12-ea1d-f450-e063-6294a90a148c | 2025-12-24 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 54a33042-a163-4f93-96cc-fbd93030e014 | 2025-12-05 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 6864b3f6-c5ad-4588-ad04-5260258c6d8c | 2025-12-05 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals, Inc. | 20eecc36-dfb7-0060-e063-6394a90a9d0b | 2025-10-16 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 6194face-c26c-46ed-bde7-1e29bfeabd88 | 2025-10-02 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 53c3f50f-57c6-441b-afea-ec43d7943d1a | 2025-09-29 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | Prefferred Pharmaceuticals Inc. | ede9846b-b4c5-4be2-9188-fd65e66cd893 | 2025-04-30 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | Rising Pharma Holdings, Inc. | 6101b9b4-f3ef-438e-a857-b4ea55ffc679 | 2025-02-21 | Warnings, Adverse reactions | 216629 ANDA216629 64980-562 |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals,Inc. | 0b3d986c-eecc-adbe-e063-6294a90a0fb2 | 2025-02-03 | Warnings, Adverse reactions | 216629 ANDA216629 |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 6c2ee3a4-afea-4e1f-84e6-def0221ad437 | 2024-01-02 | Warnings, Adverse reactions | 216629 ANDA216629 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 64980-562-01 | 64980056201 | 100 TABLET in 1 BOTTLE (64980-562-01) | 100 tablet | 2022-11-05 | 0000-00-00 | No | No | Current |
| 64980-562-10 | 64980056210 | 1000 TABLET in 1 BOTTLE (64980-562-10) | 1000 tablet | 2022-11-05 | 0000-00-00 | No | No | Current |